Different roles of SHIP1 according to the cell context: The example of blood platelets

Advances in Enzyme Regulation

Volumn 48, Issue 1, 2008, Pages 240-252

  Gratacap, Marie Pierre ^a,b   Séverin, Sonia ^a,b   Chicanne, Gaëtan ^a,b   Plantavid, Monique ^a,b   Payrastre, Bernard ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE 5 PHOSPHATASE; INOSITOL-1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; ISOENZYME; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4 BISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4-DIPHOSPHATE; POLYPHOSPHOINOSITIDE;

ANIMAL; ARTICLE; CELL LINE; DRUG EFFECT; HUMAN; LEUKEMIA CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD PLATELETS; CELL LINE; HUMANS; ISOENZYMES; JURKAT CELLS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION;

EID: 51549083000     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2007.11.004     Document Type: Article

References (85)

1. Allam A., and Marshall A.J. Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation. Immunol Lett 97 (2005) 7-17
2. Aman M.J., Lamkin T.D., Okada H., Kurosaki T., and Ravichandran K.S. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem 273 (1998) 33922-33928
3. Astle M.V., Horan K.A., Ooms L.M., and Mitchell C.A. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?. Biochem Soc Symp 74 (2007) 161-181
4. Astle M.V., Seaton G., Davies E.M., Fedele C.G., Rahman P., Arsala L., et al. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases. IUBMB Life 58 (2006) 451-456
5. Backers K., Blero D., Paternotte N., Zhang J., and Erneux C. The termination of PI3K signaling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv Enzyme Regul 43 (2003) 15-28
6. Banfic H., Downes C.P., and Rittenhouse S.E. Biphasic activation of PKBalpha/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273 (1998) 11630-11637
7. Batty I.H., Van der Kaay J., Gray A., Telfer J.F., Dixon M.J., and Downes C.P. The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2. Biochem J 407 (2007) 255-266
8. Blero D., Payrastre B., Schurmans S., and Erneux C. Phosphoinositide phosphatases in a network of signaling reactions. Pflugers Arch 455 (2007) 31-44
9. Brass L.F., Zhu L., and Stalker T.J. Minding the gaps to promote thrombus growth and stability. J Clin Invest 115 (2005) 3385-3392
10. Bodin S., Viala C., Ragab A., and Payrastre B. A critical role of lipid rafts in the organization of a key FcgammaRIIa-mediated signaling pathway in human platelets. Thromb Haemost 89 (2003) 318-330
11. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
12. Carver D.J., Aman M.J., and Ravichandran K.S. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization. Blood 96 (2000) 1449-1456
13. Chen J., De S., Damron D.S., Chen W.S., Hay N., and Byzova T.V. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104 (2004) 1703-1710
14. Damen J.E., and Krystal G. Early events in erythropoietin-induced signaling. Exp Hematol 24 (1996) 1455-1459
15. Deuter-Reinhard M., Apell G., Pot D., Klippel A., Williams L.T., and Kavanaugh W.M. SIP/SHIP inhibits Xenopus oocyte maturation induced by insulin and phosphatidylinositol 3-kinase. Cell Biol 17 (1997) 2559-2565
16. Di Paolo G., and De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 443 (2006) 651-657
17. Dong S., Corre B., Foulon E., Dufour E., Veillette A., Acuto O., et al. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J Exp Med 203 (2006) 2509-2518
18. Dyson J.M., Munday A.D., Kong A.M., Huysmans R.D., Matzaris M., Layton M.J., et al. SHIP-2 forms a tetrameric complex with filamin, actin, and GPIb-IX-V: localization of SHIP-2 to the activated platelet actin cytoskeleton. Blood 102 (2003) 940-948
19. Dyson J.M., O'Malley C.J., Becanovic J., Munday A.D., Berndt M.C., Coghill I.D., et al. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155 (2001) 1065-1079
20. Engelman J.A., Luo J.I., and Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Rev Genet 7 (2006) 606-619
21. Giuriato S., Bodin S., Erneux C., Woscholski R., Plantavid M., Chap H., et al. pp60c-src Associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets. Biochem J 348 (2000) 107-112
22. Giuriato S., Payrastre B., Drayer A.L., Plantavid M., Woscholski R., Parker P., et al. Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J Biol Chem 272 (1997) 26857-26863
23. Giuriato S., Pesesse X., Bodin S., Sasaki T., Viala C., Marion E., et al. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels. Biochem J 376 (2003) 199-207
24. Gloire G., Charlier E., Rahmouni S., Volanti C., Chariot A., Erneux C., et al. Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene 25 (2006) 5485-5494
25. Gloire G., Erneux C., and Piette J. The role of SHIP1 in T-lymphocyte life and death. Biochem Soc Trans 35 (2007) 277-280
26. Gratacap M.P., Herault J.P., Viala C., Ragab A., Savi P., Herbert J.M., et al. FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation. Blood 96 (2000) 3439-3446
27. Gratacap M.P., Payrastre B., Viala C., Mauco G., Plantavid M., and Chap H. Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem 273 (1998) 24314-24321
28. Guinebault C., Payrastre B., Racaud-Sultan C., Mazarguil H., Breton M., Mauco G., et al. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol 129 (1995) 831-842
29. Hartwig J.H., Kung S., Kovacsovics T., Janmey P.A., Cantley L.C., Stossel T.P., et al. D3 phosphoinositides and outside-in integrin signaling by glycoprotein IIb-IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate. J Biol Chem 271 (1996) 32986-32993
30. Helgason C.D., Antonchuk J., Bodner C., and Humphries R.K. Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice. Blood 102 (2003) 3541-3547
31. Helgason C.D., Damen J.E., Rosten P., Grewal R., Sorensen P., Chappel S.M., et al. Targeted disruption of SHIP leads to hematopoietic perturbations, lung pathology, and shortened life span. Genes Dev 12 (1998) 1610-1620
32. Hirsch E., Bosco O., Tropel P., Laffargue M., Calvez R., Altruda F., et al. Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15 (2001) 2019-2021
33. Huber M., Helgason C.D., Damen J.E., Scheid M., Duronio V., Liu L., et al. The role of SHIP in growth factor induced signaling. Prog Biophys Mol Biol 71 (1999) 423-434
34. Huber M., Helgason C.D., Scheid M.P., Duronio V., Humphries R.K., and Krystal G. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. EMBO J 17 (1998) 7311-7319
35. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., and Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci U S A 95 (1998) 11330-11335
36. Jackson S.P., Schoenwaelder S.M., Goncalves I., Nesbitt W.S., Yap C.L., Wright C.E., et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 11 (2005) 507-514
37. Jackson S.P., Yap C.L., and Anderson K.E. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 32 (2004) 387-392
38. Kalesnikoff J., Sly L.M., Hughes M.R., Büchse T., Rauh M.J., Cao L.P., et al. The role of SHIP in cytokine-induced signaling. Rev Physiol Biochem Pharmacol 149 (2003) 87-103
39. Kasirer-Friede A., Kahn M.L., and Shattil S.J. Platelet integrins and immunoreceptors. Immunol Rev 218 (2007) 247-264
40. Kavanaugh W.M., Pot D.A., Chin S.M., Deuter-Reinhard M., Jefferson A.B., Norris F.A., et al. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol 6 (1996 Apr 1) 438-445
41. Kovacsovics T.J., Bachelot C., Toker A., Vlahos C.J., Duckworth B., Cantley L.C., et al. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem 270 (1995) 11358-11366
42. Krause M., Leslie J.D., Stewart M., Lafuente E.M., Valderrama F., Jagannathan R., et al. Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. Dev Cell 7 (2004) 571-583
43. Kroner C., Eybrechts K., and Akkerman J.-W. Dual regulation of platelet protein kinase B. J Biol Chem 275 (2000) 27790-27798
44. Lamkin T.D., Walk S.F., Liu L., Damen J.E., Krystal G., and Ravichandran K.S. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J Biol Chem 272 (1997) 10396-10401
45. Lemmon M.A. Phosphoinositide recognition domains. Traffic 4 (2003) 201-213
46. Leslie N.R., and Downes C.P. PTEN: The down side of PI 3-kinase signalling. Cell Signal 14 (2002) 285-295
47. Lesourne R., Fridman W.H., and Daeron M. Dynamic interaction of Fc gamma receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fc epsilon receptor I signaling. J. Immunol 174 (2005) 1365-1373
48. Lioubin M.N., Algate P.A., Tsai S., Carlberg K., Aebersold A., and Rohrschneider L.R. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 10 (1996) 1084-1095
49. Liu L., Damen J.E., Hughes M.R., Babic I., Jirik F.R., and Krystal G. The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J Biol Chem 272 (1997) 8983-8988
50. March M.E., and Ravichandran K. Regulation of the immune response by SHIP. Semin Immunol 14 (2002) 37-47
51. Maxwell M.J., Yuan Y., Anderson K.E., Hibbs M.L., Salem H.H., and Jackson S.P. SHIP1 and Lyn kinase negatively regulate integrin alpha IIb beta 3 signaling in platelets. J Biol Chem 279 (2004) 32196-32204
52. Nishio M., Watanabe K., Sasaki J., Taya C., Takasuga S., Iizuka R., et al. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol 9 (2007) 36-44
53. Norris F.A., Atkins R.C., and Majerus P.W. Inositol polyphosphate 4-phosphatase is inactivated by calpain-mediated proteolysis in stimulated human platelets. J Biol Chem 272 (1997) 10987-10989
54. Ong C.J., Ming-Lum A., Nodwell M., Ghanipour A., Yang L., Williams D.E., et al. Small molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110 (2007) 1942-1949
55. Osborne M.A., Zenner G., Lubinus M., Zhang X., Songyang Z., Cantley L.C., et al. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J Biol Chem 271 (1996) 29271-29278
56. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., and Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37 (2004) 449-471
57. Pasquet J.M., Bobe R., Gross B., Gratacap M.P., Tomlinson M.G., Payrastre B., et al. A collagen-related peptide regulates phospholipase Cgamma2 via phosphatidylinositol 3-kinase in human platelets. Biochem J 342 (1999) 171-177
58. Pasquet J.M., Quek L., Stevens C., Bobe R., Huber M., Duronio V., et al. Phosphatidylinositol 3,4,5-trisphosphate regulates Ca(2+) entry via btk in platelets and megakaryocytes without increasing phospholipase C activity. EMBO J 15 19 (2000) 2793-2802
59. Paternotte N., Zhang J., Vandenbroere I., Backers K., Blero D., Kiola N., et al. SHIP2 interaction with the cytoskeletal protein vinexin. FEBS J 272 (2005) 6052-6066
60. Payrastre B., Missy K., Giuriato S., Bodin S., Plantavid M., and Gratacap M.P. Phosphoinositides key players in cell signalling, in time and space. Cell Signal 13 (2001) 377-387
61. Pendaries C., Tronchère H., Plantavid M., and Payrastre B. Phosphoinositide signaling disorders in human diseases. FEBS Lett 546 (2003) 25-31
62. Pesesse X., Backers K., Moreau C., Zhang J., Blero D., Paternotte N., et al. SHIP1/2 interaction with tyrosine phosphorylated peptides mimicking an immunoreceptor signaling motif. Adv Enzyme Regul 46 (2006) 142-153
63. Pesesse X., Deleu S., De Smedt F., Drayer L., and Erneux C. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 239 (1997) 697-700
64. Pizarro-Cerda J., and Cossart P. Subversion of phosphoinositide metabolism by intracellular bacterial pathogens. Nat Cell Biol 6 (2004) 1026-1033
65. Prevost N., Woulfe D.S., Jiang H., Stalker T.J., Marchese P., Ruggeri Z.M., et al. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci U S A 102 (2005) 9820-9825
66. Ragab A, Severin S, Gratacap MP, Aguado E, Malissen M, Jandrot-Perrus M, et al. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation; insights in the mechanism of PLC{gamma}2 activation. Blood, in press.
67. Rohrschneider L.R., Fuller J.F., Wolf I., Liu Y., and Lucas D.M. Structure, function, and biology of SHIP proteins. Genes Dev 14 (2000) 505-520
68. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 17 (1998) 1961-1972
69. Scheid M.P., Huber M., Damen J.E., Hughes M., Kang V., Neilsen P., et al. Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J Biol Chem 277 (2002) 9027-9035
70. Severin S., Gratacap M.P., Lenain N., Alvarez L., Hollande E., Penninger J.M., et al. Deficiency of Src homology 2 domain-containing inositol 5-phosphatase 1 affects platelet responses and thrombus growth. J Clin Invest 117 (2007) 944-952
71. Sly L.M., Rauh M.J., Kalesnikoff J., Büchse T., and Krystal G. SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Exp Hematol 31 (2003) 1170-1181
72. Stefan M., Koch A., Mancini A., Mohr A., Weidner K.M., Niemann H., et al. Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis. J Biol Chem 276 (2001) 3017-3023
73. Sultan C., Plantavid M., Bachelot C., Grondin P., Breton M., Mauco G., et al. Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3′,4′-bisphosphate. J Biol Chem 266 (1991) 23554-23557
74. Toker A. Phosphoinositides and signal transduction. Cell Mol Life Sci 59 (2002) 761-779
75. Tomlinson M.G., Heath V.L., Turck C.W., Watson S.P., and Weiss A. SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase. J Biol Chem 279 (2004) 55089-55096
76. Tridandapani S., Kelley T., Cooney D., Pradhan M., and Coggeshall K.M. Negative signaling in B cells: SHIP Grbs Shc. Immunol Today 18 (1997) 424-427
77. Tridandapani S., Kelley T., Pradhan M., Cooney D., Justement L.B., and Coggeshall K.M. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Mol Cell Biol 17 (1997) 4305-4311
78. Tridandapani S., Phee H., Shivakumar L., Kelley T.W., and Coggeshall K.M. Role of SHIP in FcgammaRIIb-mediated inhibition of Ras activation in B cells. Mol Immunol 35 (1998) 1135-1146
79. Trumel C., Payrastre B., Plantavid M., Hechler B., Viala C., Presek P., et al. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94 (1999) 4156-4165
80. Vandeput F., Backers K., Villeret V., Pesesse X., and Erneux C. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity. Cell Signal 18 (2006) 2193-2199
81. Van Giezen J.J., and Humphries R.G. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists. Semin Thromb Hemost 31 (2005) 195-204
82. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Kato R., Driscoll P.C., Woscholski R., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70 (2001) 535-602
83. Ware M.D., Rosten P., Damen J.E., Liu L., Humphries R.K., and Krystal G. Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. Blood 88 (1996) 2833-2840
84. Woulfe D., Jiang H., Morgans A., Monks R., Birnbaum M., and Brass L.F. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J Clin Invest 113 (2004) 441-450
85. Xu Y., Harder K.W., Huntington N.D., Hibbs M.L., and Tarlinton D.M. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22 (2005) 9-18